Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01424839 : Prospective Trial for the Diagnosis and Treatment of Intracranial Germ Cell Tumors
PhasePhase 4
AgesMin: N/A Max: N/A
Inclusion Criteria:

- Main residence in one of the participating countries

- Primary diagnosis of an intracranial germ cell tumour

- Written consent for trial participation, treatment according to the protocol and
consent for data transfer

Exclusion Criteria:

- Tumour entity other than primary intracranial germ cell tumour or CNS GCT as second

- Primary diagnosis pre-dating the opening of SIOP CNS GCT II in the participating
country of registration

- Medical, psychiatric or social conditions incompatible with trial treatment or
treatment according to protocol is not intended

- Participation within a different trial for treatment of germ cell tumours and/or
concurrent treatment within any other clinical trial. The only exceptions to this are
trials with different endpoints, involving aspects of supportive treatment which can
run parallel to SIOP CNS GCT II without influencing the outcome of this trial e.g.
trials on antiemetics, antimycotics, antibiotics, strategies for psychosocial support

- Pregnancy and lactation

- Any treatment not given according to protocol prior to registration
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557